Anticancer activity of synthetic bis(indolyl)methane-ortho-biaryls against human cervical cancer (HeLa) cells

Chem Biol Interact. 2016 Mar 5:247:11-21. doi: 10.1016/j.cbi.2016.01.017. Epub 2016 Jan 22.

Abstract

Bis(indolyl)methane appended biaryls were designed, synthesized and evaluated in human cervical cancer cell lines (HeLa) for their anticancer activities and compared against normal rat cardiac myoblasts (H9C2) cells. Compounds 1-12 were synthesized, with variations in one of the phenyl unit, in a single step by condensation of biaryl-2-carbaldehydes with indole in the presence of para-toluenesulfonic acid. Compound 1 exhibited a GI50 value of 11.00 ± 0.707 μM and the derivatives, compounds 4 and 11 showed a GI50 value of 8.33 ± 0.416 μM and 9.13 ± 0.177 μM respectively in HeLa cells and was found to be non-toxic to H9C2 cells up to 20 μM. Furthermore, compounds 1, 4 and 11 induced caspase dependent cellular apoptosis in a concentration-dependent manner, reduced mitochondrial membrane potential, inhibited the cell migration and downregulated the production of MMP-2 and MMP-9 in HeLa cells.

Keywords: Apoptosis; Biaryl; Bis(indolyl)methane; H9C2 cells; HeLa cells; Matrix metalloproteinases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Female
  • HeLa Cells
  • Humans
  • Indoles / pharmacology*
  • Membrane Potential, Mitochondrial / drug effects
  • Uterine Cervical Neoplasms / pathology*

Substances

  • Antineoplastic Agents
  • Indoles